Detection of the Three Kunitz-Type Single Domains of Membrane-Bound Tissue Factor Pathway Inhibitor (TFPI) by Flow Cytometry

Clinical Chemistry and Laboratory Medicine

Volumn 35, Issue 11, 1997, Pages 855-860

  Tiemann, Carsten ^a   Brinkmann, Thomas ^a   Kleesiek, Knut ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; POLYCLONAL ANTIBODY; RABBIT ANTISERUM; TISSUE FACTOR PATHWAY INHIBITOR;

ARTICLE; CELL LINE; CELL SURFACE; CULTURE MEDIUM; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN SECRETION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODY SPECIFICITY; ANTICOAGULANTS; CELLS, CULTURED; CULTURE MEDIA; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; HEPARIN; HUMANS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; LIPOPROTEINS; MEMBRANES; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RABBITS; RNA, MESSENGER;

ORYCTOLAGUS CUNICULUS;

EID: 0030731466     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm.1997.35.11.855     Document Type: Article

References (27)

1. Novotny WF, Girard TF, Miletich JP, Broze GJ Jr. Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein-associated coagulation inhibitor. Blood 1988; 76: 2020-2025.
2. Hamamoto T, Yamamoto M, Nordfang O, Listke Petersen JG, Foster DC, Kisliel W. Inhibitory properties of full length and truncated recombinant tissue factor pathway inhibitor (TFPI). J Biol Chem 1993; 268: 8704-10.
3. Marlar RA, Kleiss AJ, Griffin JH. An alternative extrinsic pathway of human Bloodcoagulation. Blood 1982; 60: 1352-1358.
4. Wun TC, Kretzmer KK, Girard TJ, Miletich JP, Broze GJ. Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. J Biol Chem 1988; 263: 6001-6004.
5. Girard TJ, Eddy R, Wesselschmidt RL. Structure of the human lipoprotein-associated coagulation inhibitor gene. Intron/exon gene organization and localization of the gene to chromosome J Biol Chem 1991; 266: 5036-41.
6. Hansen JB, Huseby NE, Sandset PM, Svensson B, Lyngmo V, Nordoy A. Tissue factor pathway inhibitor and lipopolysaccha-rides-evidence for association with and regulation by LDL in human plasma. Arterioscler Thromb 1994; 14: 223-229.
7. Bajaj MS, Kuppuswamy MN, Saito H, Spitzer SG, Bajaj SP. Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principle site of its synthesis. Proc Natl Acad Sci USA 1990; 87: 8869-73.
8. Brinkmann T, Kahnert H, Prohaska W, Nordfang O, Kleesiek K. Synthesis of tissue factor pathway inhibitor in human synovial cells and chondrocytes makes joints the predilected site of bleeding in haemophiliacs. Eur J Clin Chem Clin Biochem 1994; 32: 313-317.
9. Hansen JB, Huseby KR, Huseby NE, Sandset PM, Hanssen TA, Nordoy A. Effect of cholesterol lowering on intravascular pools of TFPI and its anticoagulant potential in type II hyperlipoproteinemia. Arterioscler Thromb 1995; 15: 879-885.
10. Warshawsky I, Broze GJ, Schwarz AL. The low density lipoprotein receptor-related protein mediates the cellular degradation of tissue factor pathway inhibitor. Proc Natl Acad Sci USA 1994; 91: 6664-6668.
11. Sandset PM, Albigaard U, Larsen ML. Heparin induces release of extrinsic pathway inhibitor (EPI). Thromb Res 1988; 50: 803-813.
12. Harenberg J, Malsch R. Heene DL. Tissue factor pathway inhibitor: proposed heparin recognition region. BloodCoagul Fi-brinol 1995; 6: 50-56.
13. Lindahl AK, Abildgaard U, Stokke G. Extrinsic pathway inhibitor after heparin injection: increased response in cancer patients. Thromb Res 1990; 59: 651-656.
14. Cadroy Y, Gaspin D, Lormeau JC, Boneu B, Sie P. Heparin reverses the procoagulant properties of stimulated endothelial cells. Thromb Haemostasis 1996; 75: 190-195.
15. Enjyoji K, Miyata T, Kamikubo Y, Kato H. Effect of heparin on the inhibition of factor Xa by tissue factor pathway inhibitor: a segment, Gly212-Phe243, of the third Kunitz domain is a heparin binding site. Biochemistry 1995; 34: 5725-35.
16. Broze GJ. Tissue factor pathway inhibitor. Thromb Haemostasis 1995; 74: 90-93.
17. Tiemann C, Brinkmann T, Prohaska W, Kleesiek K. Effect of cyclosporine A on the release of tissue factor pathway inhibitor (TFPI) in plasma of heart transplant patients and endothelial cell culture medium. Ann Haematol 1995; 70: A77.
18. Tiemann C, Brinkmann T, Prohaska W, Kleesiek K. Elevated concentrations of tissue factor pathway inhibitor (TFPI) in im-munosuppressed heart transplant patients. Eur J Clin Chem Clin Biochem 1995; 33: A87.
19. Tiemann C, Prohaska W, Korfer, R, Komer, M, Brinkmann T, Kleesiek K. Effect of cyclosporine A on the release of tissue factor pathway inhibitor (TFPI) from endothelial cells in heart transplant patients and cell culture. Eur J Clin Chem Clin Biochem 1997; 35: 661-667.
20. Broze GJ. Tissue factor pathway inhibitor and the current concept of Bloodcoagulation. BloodCoagul Fibrin 1995; 6: 7-13.
21. Rao LV, Rapaport I. Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation. Blood 1987; 69: 645-651.
22. Van'tveer C, Hackeng TM, Delahaye C, Sixma JJ, Bouma BN. Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor. Blood 1994; 84: 1132-42.
23. Hirsch J, Levine MN. Low molecular weight heparin. Blood 1992; 79: 1-17.
24. Hoppenstedt DA, Jeske W, Farred J, Bermes EW. The role of tissue factor pathway inhibitor in the mediation of the antithrombotic actions of heparin and low-molecular weight heparin. BloodCoagul Fibrin 1995; 6: 57-64.
25. Broze GJ. Tissue factor pathway inhibitor and the revised theory of Bloodcoagulation. Ann Rev Med 1995; 46: 103-112.
26. Collins P, Wilkie M, Razak K, Abbot S, Harley S, Bax C, et al. Cyclosporine and cremaphor modulate von Willebrand factor release from cultured human endothelial cells. Transplantation 1993; 56: 1218-23.
27. Valentin S, Nordfang O, Bregengard C, Wildgoose P. Evidence that the C-terminus of the TFPI is essential for its in vitro and in vivo interaction with lipoproteins. BloodCoagul Fibrin 1993; 4: 713-720.